Which topical anesthetic has the fastest onset among the listed options?

Which topical anesthetic has the fastest onset among the listed options?

• A. Benzocaine
• B. Lidocaine
• C. Dyclonine HCl
• D. Tetracaine HCl

Answer: (A)

Onset speed for topical anesthetics mainly depends on how quickly the drug can cross the nerve membrane to reach and block the voltage-gated sodium channels. This crossing happens most readily when the drug is in its uncharged (unionized) form. The fraction that is unionized at physiological tissue pH is governed by the drug’s pKa: lower pKa means most of the drug is uncharged in the tissue, allowing rapid diffusion into nerve endings. Benzocaine has the lowest pKa among these options, so at normal tissue pH it exists predominantly in the uncharged form. That rapid penetration into the nerve membrane enables it to block Na channels quickly, producing the fastest onset of anesthesia. Lidocaine, with a higher pKa, is more often in a charged form at physiological pH, slowing its entry into the nerve and delaying onset. The other agents also have properties (often higher pKa or formulation as salts) that reduce the uncharged fraction at tissue pH, leading to slower onset compared to benzocaine.

Onset speed for topical anesthetics mainly depends on how quickly the drug can cross the nerve membrane to reach and block the voltage-gated sodium channels. This crossing happens most readily when the drug is in its uncharged (unionized) form. The fraction that is unionized at physiological tissue pH is governed by the drug’s pKa: lower pKa means most of the drug is uncharged in the tissue, allowing rapid diffusion into nerve endings.

Benzocaine has the lowest pKa among these options, so at normal tissue pH it exists predominantly in the uncharged form. That rapid penetration into the nerve membrane enables it to block Na channels quickly, producing the fastest onset of anesthesia.

Lidocaine, with a higher pKa, is more often in a charged form at physiological pH, slowing its entry into the nerve and delaying onset. The other agents also have properties (often higher pKa or formulation as salts) that reduce the uncharged fraction at tissue pH, leading to slower onset compared to benzocaine.